Canadian Life Sciences NewsUncategorized

Depression, PTSD and Addiction Levels Continue to Rise as Omicron Cases Increase

Depression, PTSD and Addiction Levels Continue to Rise as Omicron Cases Increase

Data from the Mental Health Index shows that mental health in America has hit an all-time low as the COVID-19 pandemic rages on. The rates of addiction, depression and post-traumatic stress disorder are soaring, as cases of omicron increase. Currently, one in four workers in America has screened positive for PTSD. This is a 54% increase in the last three months and a 135% increase when compared to the levels recorded prior to the pandemic.

Rates of depression have also grown by 86% since fall, which is 63% higher than prepandemic levels. A significant increase in addiction in men has also been recorded, with figures showing that between September and December last year, addiction rose by 80%. Social anxiety and depression among men has also risen by 161% and 118% respectively, with data showing…

Read more »

NOTE TO INVESTORS: The latest news and updates relating to Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) are available in the company’s newsroom at

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published:

BioMedWire (BMW)
San Francisco, California
415.949.5050 Office

BioMedWire is part of the InvestorBrandNetwork.

Related Articles

Back to top button